– Health Gauge Initiates FDA Approval Process –
TORONTO, March 30, 2021 /PRNewswire/ — AI/ML Innovations Inc. (CSE: AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its subsidiary, Health Gauge, has secured key strategic partnerships to help ensure that it scales its market opportunities and enhances its ability to effectively satisfy growing product demand. Specifically, these partnerships are intended to assist Health Gauge in addressing FDA requirements for entry into the US marketplace, as well as implementation of the most stringent of data management privacy and security standards, as Health Gauge looks towards international expansion.
“Health Gauge views the entry into the US health and wellness space as a logical and critical near-term milestone” said Tim Daniels, Executive Chairman of AI/ML. “In order to garner requisite approvals and the utmost of confidence in Health Gauge’s portfolio of products and services by retail users, channel partners, enterprise level clients and governmental regulators, Health Gauge is utilizing the resources of industry leading partners who have the expertise to help ensure that we expeditiously and effectively meet and exceed the highest of industry standards.”
Zi Medical (https://www.zi-medical.com/)
Health Gauge is working closely with Zi Medical to ensure it is addressing core regulatory requirements for entry into the US and Canadian markets initially, to be followed by other global markets of strategic importance to Health Gauge. Zi Medical is a Registered U.S. FDA Agent who provides services globally to medical device, IVD and pharma companies in the areas of regulatory submissions and filings, strategy, international product registration and licenses, regulatory training and support, and quality compliance. The primary regions they cover include the USA, the EU, China, Taiwan, Hong Kong, Singapore, Japan, Korea, Malaysia, Philippines, Singapore, Indonesia, India, Thailand, Vietnam, New Zealand, Australia, Mexico, Argentina, and Brazil.
Health Gauge is deploying its core architecture with MedStack to ensure the highest level of compliance to privacy and security protection of Health Gauge’s client data. MedStack empowers healthcare enterprises and health solution providers to onboard digital innovations faster, by helping companies meet privacy, and security expectations up front, by way of standardization of architecture and regulation-mapped policies.
Privacy Horizon (https://privacyhorizon.com/)
Privacy Horizon’s Virtual Privacy and Security Office is equipping Health Gauge with the policy frameworks and capabilities necessary to safeguard the privacy rights of individuals and protect personal information from loss or theft, unauthorized access, modification, copying, collection, use, unauthorized disclosure or retention.
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
For more information about AI/ML Innovations:
For detailed information please see AI/ML’s website at https://aiml-innovations.com/
or the Company’s filed documents at www.sedar.com
For further information: Blake Fallis at (778) 405-0882 or [email protected]
Investor slidedeck: https://aiml-innovations.com/wp-content/uploads/2021/01/AIML-mini-1-21.pdf
Corporate video: https://www.youtube.com/watch?v=k2QSjo7clXc&feature=youtu.be
Official YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ
About AI/ML Innovations Inc.
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning areas of artificial intelligence (AI) and machine learning (ML), with an initial focus on emerging companies in the digital healthcare space. AI/ML’s shares are traded on the Canadian Securities Exchange under the symbol “AIML”. AI/ML’s first acquisition was 70% ownership of Health Gauge.
About Health Gauge
Health Gauge’s patent-pending solution is a personal health monitoring & management system, which combines the latest wearable health monitors with sophisticated artificial intelligence software tools and proprietary cloud computing software, to help caregivers, patients, and healthcare professionals, access and utilize relevant data, resulting in better recovery outcomes and healthy living objectives through the ability to make immediate and better health choices.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Cautionary and Forward-Looking Statements
Certain information in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including but not limited to, the uncertainty of competition by other industry players, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals and the ability to raise additional capital as may be needed in the future. Readers are cautioned that the assumptions used in preparing such information, although considered reasonable at the time of preparation, may prove imprecise and undue reliance should not be placed on forward-looking statements. Forward-looking statements in this press release are expressly qualified by this cautionary statement.
The forward-looking statements in this press release are made as of the date of this press release, and the Company undertakes no obligations to update publicly or to revise any of the included forward-looking statements, whether because of new information, future events or otherwise, except as expressly required by applicable securities law.
+1 (778) 405-0882
View original content:http://www.prnewswire.com/news-releases/aimls-health-gauge-prepares-for-entry-into-us-marketplace-301257763.html
SOURCE AI/ML Innovations Inc.